Product Details

Adlyxine

Lixisenatide
0.05 mg/mL
Solution for Injection
3-mL Prefilled Pen

DIN/PIN/NPN

02464276

Manufacturer

Sanofi-Aventis Canada Inc.

Formulary Listing Date

2019-12-20  

Unit Price

56.9800

Amount MOH Pays

56.9800

Coverage Status

Discontinued Drug General Benefit Insulin or Oral Hypoglycemic Product

ODB Formulary Therapeutic Classification

Therapeutic Note

Lixisenatide 0.05 mg/mL Solution for Injection in 3-mL Prefilled Pen: For the treatment of type 2 diabetes in combination with metformin and one of either sulfonylurea, pioglitazone, or basal insulin, when diet and exercise plus dual therapy with one of the above do not achieve adequate glycemic control.

ATC Code

A10BJ03

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph